Explore the latest in hepatitis B, including recent advances in diagnosis and antiviral treatment, prevention of complications, and more.
This JAMA Patient Page reviews the US Preventive Services Task Force’s 2020 recommendation to screen for hepatitis B infection in adolescents and adults at increased risk (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B virus infection summarizes published evidence on the benefits and harms of screening and interventions for hepatitis B infection in nonpregnant adolescents and adults.
This 2020 US Preventive Services Task Force Recommendation Statement recommends screening for HBV infection in adolescents and adults at increased risk for infection (B recommendation).
This cohort study uses data from the electronic health records of Kaiser Permanente Southern California members to assess whether the number of doses in a hepatitis B virus vaccine series is associated with completion of the series among US adults.
This cross-sectional study used NHANES data from 1999 to 2016 to assess the trends in self-reported hepatitis B vaccination coverage and serologic evidence of immunity among children and adolescents in the US.
This survey study evaluates adult Medicaid beneficiaries’ access to adult immunization services through review of vaccination benefits coverage in Medicaid programs across the 50 states and the District of Columbia.
This prognostic study evaluates the feasibility and availability of a novel hepatitis B virus DNA index to assess the prognosis of patients with hepatitis B virus–related hepatocellular carcinoma.
This cross-sectional study compares the prevalence of diagnosis with chronic hepatitis B infection from a large database of privately insured patients with the prevalence of infection found in the National Health and Nutrition Examination Survey to estimate the prevalence of undiagnosed chronic hepatitis B in the US.
This systematic review to support the 2019 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B infection in pregnant women summarizes published evidence on the benefits and harms of hepatitis B infection screening and case management in pregnant women.
This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening for hepatitis B virus infection in pregnant women.
This 2019 Recommendation Statement from the US Preventive Services Task Force reaffirms the prior recommendation to screen pregnant women for hepatitis B virus infection at their first prenatal visit (A recommendation).
This cohort study examines changes in the demographic and clinical characteristics and outcomes of patients with newly diagnosed cirrhosis.
This population-based cohort study examines the associations between chronic hepatitis B virus infection and risk of all cancer types among Chinese adults.
This nationwide cohort study examines the risk of hepatocellular carcinoma in Taiwanese patients with chronic hepatitis B who are receiving daily aspirin therapy.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: